3rd Quarter - Report

UNIVERSITY OF PITTSBURGH for UNIVERSITY OF PITTSBURGH

Firm
Client
Income
—
Expenses
$140,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

In support of FY25 Appropriations. In support of FY25 Labor/HHS/Education appropriations for the National Institutes of Health, including RegionalBiocontainment Labs; international education; Pell Grants; Supplemental Educational Opportunity Grants; Federal Work-study; and TRIO programs.In support of FY25 Commerce, Justice, Science appropriations for the National Science Foundation, Aeronautics Research at NASA and NIST. Insupport of FY25 Defense Appropriations, including Science and Technology accounts for basic research, and specific increases in humanperformance, soldier protection, military medicine, regenerative medicine, additive manufacturing, and defense health research programs funded through the Congressionally Directed Medical Research Programs. In support of FY25 Interior Appropriations for the National Endowment for theHumanities. In support of FY25 State/Foreign Operations Appropriations for selected educational and cultural exchange programs, and certainUSAID development assistance funding for wheelchair research and programs. In support of FY25 Transportation/HUD Appropriations for Housing research and technology. In support of an Administration FY25 defense budget request that prioritizes Science and Technology, and within that levelprioritizes defense basic research. In support of funding for biomanufacturing initiatives.

LobbyistCovered position, as disclosed
JOHN MICHAEL RINGLER Senior Director for Federal Relations

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Sports/Athletics SPO

In support of potential Federal legislation providing a level playing field for Name, Image, and Likeness activity.

LobbyistCovered position, as disclosed
JOHN MICHAEL RINGLER Senior Director for Federal Relations

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

In support of biomanufacturing initiatives.

LobbyistCovered position, as disclosed
JOHN MICHAEL RINGLER Senior Director for Federal Relations

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Natl Science Foundation (NSF)

Medical/Disease Research/Clinical Labs MED

NIH's proposed cap of 15% on F&A expenditures. Impacts of Executive Orders and agency directives on University operations and funded research projects.

LobbyistCovered position, as disclosed
JOHN MICHAEL RINGLER Senior Director for Federal Relations

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.